These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 8526243)
1. Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder. Lam RW; Gorman CP; Michalon M; Steiner M; Levitt AJ; Corral MR; Watson GD; Morehouse RL; Tam W; Joffe RT Am J Psychiatry; 1995 Dec; 152(12):1765-70. PubMed ID: 8526243 [TBL] [Abstract][Full Text] [Related]
2. A placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorder. Moscovitch A; Blashko CA; Eagles JM; Darcourt G; Thompson C; Kasper S; Lane RM; Psychopharmacology (Berl); 2004 Feb; 171(4):390-7. PubMed ID: 14504682 [TBL] [Abstract][Full Text] [Related]
3. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. Lam RW; Levitt AJ; Levitan RD; Enns MW; Morehouse R; Michalak EE; Tam EM Am J Psychiatry; 2006 May; 163(5):805-12. PubMed ID: 16648320 [TBL] [Abstract][Full Text] [Related]
5. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients. Nemeroff CB; Thase ME; J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158 [TBL] [Abstract][Full Text] [Related]
6. Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group. Michelson D; Lydiard RB; Pollack MH; Tamura RN; Hoog SL; Tepner R; Demitrack MA; Tollefson GD Am J Psychiatry; 1998 Nov; 155(11):1570-7. PubMed ID: 9812120 [TBL] [Abstract][Full Text] [Related]
7. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up. Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027 [TBL] [Abstract][Full Text] [Related]
8. Mood, major depression, and fluoxetine response in cigarette smokers. Dalack GW; Glassman AH; Rivelli S; Covey L; Stetner F Am J Psychiatry; 1995 Mar; 152(3):398-403. PubMed ID: 7864266 [TBL] [Abstract][Full Text] [Related]
9. Fluoxetine versus placebo in depressed alcoholic cocaine abusers. Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208 [TBL] [Abstract][Full Text] [Related]
10. Moclobemide and fluoxetine in treatment of seasonal affective disorder. Partonen T; Lönnqvist J J Affect Disord; 1996 Nov; 41(2):93-9. PubMed ID: 8961036 [TBL] [Abstract][Full Text] [Related]
11. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385 [TBL] [Abstract][Full Text] [Related]
12. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial. Gillin JC; Rapaport M; Erman MK; Winokur A; Albala BJ J Clin Psychiatry; 1997 May; 58(5):185-92. PubMed ID: 9184611 [TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder. Garakani A; Martinez JM; Marcus S; Weaver J; Rickels K; Fava M; Hirschowitz J Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936 [TBL] [Abstract][Full Text] [Related]
14. Fluoxetine once every third day in the treatment of major depressive disorder. Tural U; Onder E Eur Arch Psychiatry Clin Neurosci; 2003 Dec; 253(6):307-12. PubMed ID: 14714120 [TBL] [Abstract][Full Text] [Related]
15. Fluoxetine in the prevention of depressive recurrences: a double-blind study. Gilaberte I; Montejo AL; de la Gandara J; Perez-Sola V; Bernardo M; Massana J; Martin-Santos R; Santiso A; Noguera R; Casais L; Perez-Camo V; Arias M; Judge R; J Clin Psychopharmacol; 2001 Aug; 21(4):417-24. PubMed ID: 11476126 [TBL] [Abstract][Full Text] [Related]
16. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies. Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial. Lecrubier Y; Clerc G; Didi R; Kieser M Am J Psychiatry; 2002 Aug; 159(8):1361-6. PubMed ID: 12153829 [TBL] [Abstract][Full Text] [Related]
18. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036 [TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled study of fluoxetine in depressed patients with Alzheimer's disease. Petracca GM; Chemerinski E; Starkstein SE Int Psychogeriatr; 2001 Jun; 13(2):233-40. PubMed ID: 11495397 [TBL] [Abstract][Full Text] [Related]
20. Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder. Judd LL; Rapaport MH; Yonkers KA; Rush AJ; Frank E; Thase ME; Kupfer DJ; Plewes JM; Schettler PJ; Tollefson G Am J Psychiatry; 2004 Oct; 161(10):1864-71. PubMed ID: 15465984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]